Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

HB 1099Session 2026

reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.

Enrolled March 3, 2026

<strong>We're sorry but South Dakota Legislature Website doesn't work properly without JavaScript enabled. Please enable it to continue.</strong>

Your browser is not supported

Please update your browser or download one of the following browsers:


Chrome
Firefox
Edge

Official text from the South Dakota Legislature. Formatting has been adapted for reading on Ratifi.